Compounds > 1-deoxynojirimycin
Page last updated: 2024-08-23

1-deoxynojirimycin and eliglustat

1-deoxynojirimycin has been researched along with eliglustat in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aerts, JM; Ferraz, MJ; Hollak, CE; Mirzaian, M; Overkleeft, HS; Smid, BE; Verhoek, M; Wisse, P1
Baris, H; Cohen, IJ; Mistry, PK; Sands, MS1

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and eliglustat

ArticleYear
Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients.
    Orphanet journal of rare diseases, 2016, Mar-24, Volume: 11

    Topics: 1-Deoxynojirimycin; Enzyme Inhibitors; Enzyme Replacement Therapy; Female; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Humans; Male; Pyrrolidines

2016
Overcoming the Next Barriers to Successful Therapy.
    Pediatric endocrinology reviews : PER, 2016, Volume: 13 Suppl 1

    Topics: 1-Deoxynojirimycin; Administration, Oral; Cellulose; Daucus carota; Drug Delivery Systems; Drug Discovery; Enzyme Inhibitors; Enzyme Replacement Therapy; Fabry Disease; Gaucher Disease; Humans; Lysosomal Storage Diseases; Mucolipidoses; Pyrrolidines; Rare Diseases

2016